Centaurus Financial, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Centaurus Financial, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$1.26 - $1.79 $8,820 - $12,530	7,000 Added 53.85%	20,000 $33,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $20,930 - $33,020	13,000 New	13,000 $24,000
Q1 2023 May 17, 2023	BUY	$1.2 - $2.19 $2,400 - $4,380	2,000 Added 17.39%	13,500 $18,000
Q4 2022 Feb 10, 2023	BUY	$1.63 - $3.52 $18,745 - $40,480	11,500 New	11,500 $19,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.